US2005009062A1PendingUtilityA1
Phosphodiesterase 10
Priority: Feb 23, 1998Filed: May 11, 2004Published: Jan 13, 2005
Est. expiryFeb 23, 2018(expired)· nominal 20-yr term from priority
Inventors:Kate Loughney
C12N 9/16A61K 38/00A61P 43/00
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides novel human PDE10 polypeptides, polynucleotides encoding the polypeptides, expression constructs comprising the polynucleotides, host cells transformed with the expression constructs; methods for producing PDE10 polypeptides; antisense polynucleotides; and antibodies specifically immunoreactive with the PDE10 polypeptides. The invention further provides methods to identify binding partners of PDE 10, and more particularly, binding partners that modulate PDE10 enzyme activity.
Claims
exact text as granted — not AI-modified1 . A purified and isolated PDE10 polypeptide.
2 .- 33 . (Canceled)Join the waitlist — get patent alerts
Track US2005009062A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.